Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. (HRMY) Stock Overview

Explore Harmony Biosciences Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

HRMY●NASDAQ
HealthcareBiotechnology
$36.01
$0.69(1.95%)
U.S. Market opens in 4h 32m

Harmony Biosciences Holdings, Inc. (HRMY)

Meyka AI Score

Z

Key Financials

Market Cap2.1B
P/E Ratio14.33
EPS (TTM)$2.48
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$33.40
3 Months$29.00
1 Year Target$32.30

HRMY Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Harmony Biosciences Holdings, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HRMY on the NASDAQ shows an RSI of 55.22, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $32.30 for the NASDAQ listing.

Key metrics behind Harmony Biosciences Holdings, Inc.'s NASDAQ-traded stock include a P/E ratio of 14.33 and a market capitalization of 2.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of HRMY on the NASDAQ.

Price Performance (NASDAQ: HRMY)

1-Day Change
1.95%
5-Day Change
-1.37%
1-Month Change
1.52%
3-Month Change
15.97%
6-Month Change
-4.43%
Year-to-Date (YTD) Change
-3.77%
1-Year Change
0.70%
3-Year Change
2.71%
5-Year Change
40.23%
All-Time (Max) Change
-2.70%

Contact Information

https://www.harmonybiosciences.com
484 539 9800
630 West Germantown Pike, Plymouth Meeting, PA, 19462

Company Facts

2,930 Employees
IPO DateAug 19, 2020
CountryUS
Actively Trading

Frequently Asked Questions